At Chiesi Pakistan, we recognize the profound impact that fertility has on the lives of individuals and families. Our Women's Health portfolio is currently focused on supporting assisted reproduction through clomiphene citrate, a trusted therapy designed to help optimize fertility treatment outcomes. We are committed to providing healthcare professionals with high-quality, evidence-based solutions that contribute to effective fertility management while supporting patients on their journey toward parenthood. Guided by our purpose of improving lives, we continue to advance patient-centered care by delivering therapies that inspire hope and help make the dream of starting a family a reality.
Prolifen® is a Human Menopausal Gonadotropin (hMG) therapy indicated for the management of infertility as part of assisted reproductive treatments. Backed by scientific research and established clinical evidence, Prolifen® supports controlled ovarian stimulation, follicular development, and ovulation induction in women undergoing fertility treatment. By providing the hormonal support required for successful follicle maturation, it helps fertility specialists optimize treatment outcomes through individualized protocols. Manufactured to high international quality standards, Prolifen® reflects Chiesi's commitment to delivering reliable, evidence-based solutions that support patients on their journey toward parenthood
Clomiphene citrate 50mg
Capsule
For the treatment of ovulatory failure in women also in patients with ovarian dysfunction. Commonly associated diagnosis includes polycystic ovary syndrome, lactation amenorrhea syndrome, psychogenic amenorrhea, and certain cases of secondary amenorrhea of undetermined etiology. An additional indication is post-oral contraceptive amenorrhea
